<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=314834185700910&amp;ev=PageView&amp;noscript=1">

New Update: Healthcare Costs Increasing by Over 60% in Some States. Will you be impacted?

Learn More

Navigating Sequence Risk in Retirement: Lessons and Strategies for Regeneron Pharmaceuticals Employees

image-table

Healthcare Provider Update: Healthcare Provider for Regeneron Pharmaceuticals: Regeneron Pharmaceuticals primarily collaborates with a range of healthcare providers, including hospitals, specialty clinics, and other medical organizations that focus on treating conditions related to its drug portfolio. The company often works with health systems, managed care organizations, and practices that specialize in therapeutic areas such as oncology, ophthalmology, and immunology, with notable partnerships aimed at advancing clinical research and access to its innovative treatments. Potential Healthcare Cost Increases in 2026: As we approach 2026, healthcare costs are projected to surge significantly, largely due to the anticipated expiration of enhanced federal subsidies under the Affordable Care Act and continued inflation in medical expenses. Reports suggest that some states may face premium hikes exceeding 60%, potentially increasing out-of-pocket costs for enrollees by up to 75%. This turbulence stems from a convergence of higher medical costs, substantial drug spending, and a regulatory landscape that pressures insurers to increase rates. Without timely congressional action to renew premium tax credits, many consumers could be priced out of affordable healthcare coverage. Click here to learn more

'Regeneron Pharmaceuticals employees approaching retirement should recognize that the sequence of market returns in their early years can influence the longevity of their income far more than the average return itself, making disciplined withdrawal strategies and diversified income planning essential.' – Brent Wolf, a representative of The Retirement Group, a division of Wealth Enhancement.

'Regeneron Pharmaceuticals employees nearing retirement can benefit from understanding how market downturns early in retirement may have lasting effects, and from adopting flexible, research-based withdrawal and allocation strategies to help sustain their income over time.' – Paul Bergeron, a representative of The Retirement Group, a division of Wealth Enhancement.

In this article we will discuss:

  1. Historical examples of sequence-of-returns risk and their effects on retirement income.

  2. Why the first years of retirement are most critical for portfolio sustainability.

  3. Research‑backed strategies for managing sequence risk and supporting long‑term retirement goals.

Contributed by Paul Bergeron and Brent Wolf of Wealth Enhancement

For Fortune 500 employees approaching retirement, recognizing the timing of returns—not just the average return—can be critical to keeping income going over the long term. This concept, known as sequence-of‑returns risk, shows how poor early market performance in retirement can have a lasting impact on a withdrawal plan, even if long-term averages seem strong. Historical market data provides clear examples of this risk and offers practical methods for responding to it.

Historical examples of sequence risk

Fortune 500 retirees entering retirement during tough market cycles face situations similar to the declines seen in the late 1960s, when the market hit two bear markets (1968–70 and 1973–74) alongside high inflation. The S&P 500 dropped roughly 48% during the 1973–74 bear market, compounding inflation-related difficulties. 1  Likewise, those retiring in 2000 endured two severe bear markets in the decade, while 2022 proved one of the toughest years for balanced portfolios, with sharp drops in both U.S. stocks and high-quality bonds.

Why the early years matter most

For a Fortune 500 retiree, significant losses in the first five to ten years of retirement—combined with regular withdrawals—can shrink the number of shares left to rebound when markets recover. Academic studies and industry research repeatedly show that even with the same average return, the order of gains and losses plays a huge role in retirement outcomes.

Research-backed strategies to manage sequence risk

One effective method for Fortune 500 retirees is keeping a mix of asset types to help weather downturns. Cash and bonds can act as “shock absorbers” for immediate expenses, reducing the need to sell stocks during market dips. Flexible withdrawal approaches—such as adjusting withdrawals within set guardrails—have been shown to support portfolio longevity better than fixed-dollar withdrawal methods.

Staging risk in a retirement portfolio—by holding one to two years of expenses in cash-like assets and several years in short‑ to intermediate‑term bonds—may give equities time to recover before they're tapped for income. For some Fortune 500 retirees, delaying income sources like Social Security can help raise total lifetime income and lessen the need to tap investments during volatile times. Thoughtful rebalancing and managing tax lots, especially during downturns, can also help maintain equity exposure and extend portfolio lifespan.

Implications for retirement planning

While higher stock allocations may offer greater long-term growth potential, they also increase sequence risk in early retirement for Fortune 500 workers. Historically, balanced portfolios—often with 30% to 50% equities for income-focused funds—have supported more resilient initial withdrawal rates compared to all-stock strategies. 2  Strong early-market results can set up long-term success, but disciplined spending limits, guardrails, and rebalancing remain key.

Featured Video

Articles you may find interesting:

Loading...

Sources:

1.The New York Times. ' What Happens When Stock Markets Become Bears ,' by William Davis, Karl Russell, and Stephen Gandel. 13 June 2022. 

2. Vanguard UK. ' Sustainable Spending Rates in Turbulent Markets ,' by Daga, Ankul, et al. Mar. 2021, pp. 1–7. 

Other Resources:

1. Guyton, Jonathan T., and William J. Klinger. “ Decision Rules and Maximum Initial Withdrawal Rates .”  Journal of Financial Planning , vol. 19, no. 3, Mar. 2006, pp. 48–50, 52–54, 56–58. Financial Planning Association.

2. “ Timeline of U.S. Stock Market Crashes .”  Investopedia , 30 Oct. 2024, section “The 1973–74 Oil Crisis Bear Market.”

3. ' When to Start Receiving Retirement Benefits. ' Social Security Administration, Pub. No. 05-10147, May 2024, pp. 1–2.

4. Arnott, Amy C., CFA, and Ivanna Hampton. “ Why More Diversification Doesn’t Mean Better Returns .”  Morningstar , 7 June 2024.

What is the 401(k) plan offered by Regeneron Pharmaceuticals?

The 401(k) plan at Regeneron Pharmaceuticals is a retirement savings plan that allows employees to save a portion of their salary on a tax-deferred basis.

How can employees of Regeneron Pharmaceuticals enroll in the 401(k) plan?

Employees can enroll in the Regeneron Pharmaceuticals 401(k) plan by completing the enrollment process through the company’s HR portal or by contacting the HR department for assistance.

What types of contributions can employees make to the Regeneron Pharmaceuticals 401(k) plan?

Employees can make pre-tax contributions, Roth (after-tax) contributions, and potentially catch-up contributions if they are eligible.

Does Regeneron Pharmaceuticals offer a company match for the 401(k) contributions?

Yes, Regeneron Pharmaceuticals offers a company match for employee contributions to the 401(k) plan, which helps enhance retirement savings.

What is the vesting schedule for the Regeneron Pharmaceuticals 401(k) company match?

The vesting schedule for the company match in the Regeneron Pharmaceuticals 401(k) plan typically follows a graded vesting schedule, which employees can review in the plan documents.

Can employees take loans against their 401(k) savings at Regeneron Pharmaceuticals?

Yes, Regeneron Pharmaceuticals allows employees to take loans against their 401(k) savings, subject to specific terms and conditions outlined in the plan.

What investment options are available in the Regeneron Pharmaceuticals 401(k) plan?

The Regeneron Pharmaceuticals 401(k) plan offers a variety of investment options, including mutual funds, target-date funds, and other investment vehicles to suit different risk tolerances.

How often can employees change their contribution amounts to the Regeneron Pharmaceuticals 401(k) plan?

Employees can change their contribution amounts to the Regeneron Pharmaceuticals 401(k) plan at any time, subject to the plan's guidelines.

What happens to the 401(k) savings if an employee leaves Regeneron Pharmaceuticals?

If an employee leaves Regeneron Pharmaceuticals, they have several options for their 401(k) savings, including rolling over to another retirement account, cashing out, or leaving the funds in the plan if allowed.

Are there any fees associated with the Regeneron Pharmaceuticals 401(k) plan?

Yes, there may be fees associated with the Regeneron Pharmaceuticals 401(k) plan, including administrative fees and investment-related fees, which are disclosed in the plan documents.

New call-to-action

Additional Articles

Check Out Articles for Regeneron Pharmaceuticals employees

Loading...

For more information you can reach the plan administrator for Regeneron Pharmaceuticals at , ; or by calling them at .

*Please see disclaimer for more information

Relevant Articles

Check Out Articles for Regeneron Pharmaceuticals employees